Another molecular pathway to consider would be GSK3β, which has been implicated in AD pathogenesis [116], primarily through the hyperphosphorylation of tau, reduction in acetylcholine synthesis, and elevation of Aβ production. Here, MAPT is linked to Alzheimer disease.